Related Experiment Video
Updated: Jun 12, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Hepatocyte growth factor and clinical diabetes in postmenopausal women
Swapnil N Rajpathak1, Sylvia Wassertheil-Smoller, Jill Crandall
1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA. swapnil.rajpathak@einstein.yu.edu
Objective:
To investigate the association between circulating levels of hepatocyte growth factor (HGF), a mesenchymal-derived pleiotrophic factor that is elevated in obesity, and the prevalence of type 2 diabetes.
Research Design And Methods:
A cross-sectional analysis among 892 postmenopausal women within the Women's Health Initiative Observational Study (WHI-OS).
Results:
HGF levels positively correlated with BMI and homeostasis model assessment for insulin resistance. In the multivariable analysis comparing the highest tertile with the lowest tertile of HGF, the odds ratio for prevalent diabetes was 2.47 (95% CI [1.12-5.47], P for trend = 0.014) after accounting for age, race, BMI, and other risk factors for diabetes.
Conclusions:
HGF levels are associated with the presence of type 2 diabetes in postmenopausal women. Future studies should consider the prospective evaluation of the association of HGF with the development of type 2 diabetes.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis